Globe Newswire

• Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2
• Additional analyses of INAVO120 will be presented in an oral abstract session at the 2024 American Society of Clinical Oncology Annual Meeting
• The target action date for the FDA decision is 27 November, 2024

Basel, 29 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has... (continue reading...)

Company announcement no. 28 / 2024Schindellegi, Switzerland – 29 May 2024

Trifork Group presents mid-term targets and strategic ambitions at Capital Markets Day in Copenhagen

Today, Trifork Group holds its first-ever Capital Markets Day in Copenhagen. Presentations will begin at 12:30 CEST and will focus on educating investors and other stakeholders about Trifork’s culture, organizational model, go-to-market model, technology capabilities,... (continue reading...)

LONDON, 29 May. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire.

GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.

Disclaimer

The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.

If you... (continue reading...)

James Hamilton succeeds Shawn Kinney, bringing over 25 years of industry expertise

Lee, MA, May 29, 2024 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), the Sterile Division of Sharp, is pleased to announce the appointment of James Hamilton as the new President. This transition comes as Shawn Kinney steps down from his role as President to retire, but he will remain on staff to provide support and guidance to the company.

James Hamilton brings over 25... (continue reading...)

The shares in Lerøy Seafood Group ASA will be quoted ex-dividend NOK 2.50 per share as of today, 29 May 2024.This information is subject to the disclosure requirements pursuant to Section 5-12 to the Norwegian Securities Trading Act.